Balance Sheet
Cash Flow Statement
Beginning Cash Balance
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dr Reddys Laboratories (RDY) Depreciation & Amortization (CF): 2017-2023

Historic Depreciation & Amortization (CF) for Dr Reddys Laboratories (RDY) over the last 1 years, with Mar 2023 value amounting to $27.0 million.

  • Dr Reddys Laboratories' Depreciation & Amortization (CF) was N/A to $27.0 million in Q1 2023 from the same period last year, while for Mar 2023 it was $27.0 million, marking a year-over-year change of. This contributed to the annual value of $200.0 million for FY2025, which is 12.36% up from last year.
  • According to the latest figures from Q1 2023, Dr Reddys Laboratories' Depreciation & Amortization (CF) is $27.0 million, which was up 96,428,471.43% from $28 recorded in Q4 2020.
  • In the past 5 years, Dr Reddys Laboratories' Depreciation & Amortization (CF) registered a high of $27.0 million during Q1 2023, and its lowest value of $28 during Q4 2020.
  • Moreover, its 1-year median value for Depreciation & Amortization (CF) was $27.0 million (2023), whereas its average is $27.0 million.